Clinical Trial: Bioequivalence Study Between Adagrasib Reference Tablets and High Drug Load Tablets

U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT06801418) titled 'Bioequivalence Study Between Adagrasib Reference Tablets and High Drug Load Tablets' on Jan. 24.

Brief Summary: This is a study to evaluate bioequivalence between adagrasib reference tablets and high drug load tablets in healthy adult participants.

Study Start Date: Jan. 28

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: Adagrasib

Specified dose on specified days

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Mirati Therapeutics Inc.

Disclaimer: Curated by HT Syndication....